6185 — Cansino Biologics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapMomentum Trap

Annual balance sheet for Cansino Biologics, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	5,114	7,783	5,947	4,120	3,195
Net Total Accounts Receivable
Net Total Receivables	136	631	1,106	699	796
Total Inventory
Total Other Current Assets
Total Current Assets	5,421	9,290	7,730	5,181	4,282
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	917	2,317	3,179	3,134	2,748
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	6,748	11,874	11,469	9,319	7,958
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	413	2,875	2,942	2,592	1,772
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	677	3,879	4,721	4,044	3,048
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Other Equity
Total Equity	6,071	7,995	6,748	5,275	4,910
Total Liabilities & Shareholders' Equity	6,748	11,874	11,469	9,319	7,958
Total Common Shares Outstanding